posted on 2021-02-18, 09:12authored byC. Christiansen, J. E. Castillo-Fernandez, A. Domingo-Relloso, W. Zhao, J. S. El-Sayed Moustafa, P.-C. Tsai, J. Maddock, K. Haack, S. A. Cole, S. L. R. Kardia, M. Molokhia, M. Suderman, C. Power, C. Relton, A. Wong, D. Kuh, A. Goodman, K. S. Small, J. A. Smith, M. Tellez-Plaza, A. Navas-Acien, G. B. Ploubidis, R. Hardy, J. T. Bell
Additional file 2: Table S1. Statistically significant CpGs in relation to current versus never smoking status at false discovery rate (FDR) < 0.01. Table S2. Statistically significant CpGs in relation to current versus never smoking status at a Bonferroni-adjusted threshold (P value = 6.25 × 10–8). Table S3. Statistically significant CpGs in relation to former versus never smoking status at false discovery rate (FDR) < 0.01. Table S4. Statistically significant CpGs in replication meta-analysis relation to current versus non-smoking status at a Bonferroni-adjusted threshold (P value = 9.5 × 10−5). Table S5. Pathway Analysis (IPA) results.
Funding
National Institutes of Health Economic and Social Research Council Wellcome Trust Medical Research Council FP7 Ideas: European Research Council National Heart, Lung, and Blood Institute Foundation for the National Institutes of Health “la Caixa” Foundation